Cargando…
Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial
INTRODUCTION: To elucidate in polymyalgia rheumatica (PMR) the role of tumor necrosis factor (TNF) α and the therapeutic potential of blockade with soluble TNF-α receptor, we carried out the first randomized controlled trial with etanercept in PMR. METHODS: Twenty newly diagnosed, glucocorticoid (GC...
Autores principales: | Kreiner, Frederik, Galbo, Henrik |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991007/ https://www.ncbi.nlm.nih.gov/pubmed/20854662 http://dx.doi.org/10.1186/ar3140 |
Ejemplares similares
-
Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment
por: Kreiner, Frederik Flindt, et al.
Publicado: (2012) -
Response to 'Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial'
por: Watson, Pippa, et al.
Publicado: (2011) -
Gene expression profiling in patients with polymyalgia rheumatica before and after symptom-abolishing glucocorticoid treatment
por: Kreiner, Frederik Flindt, et al.
Publicado: (2017) -
Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969) -
Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)